The area extending 2 cm above to 2 cm below the esophagogastric junction (EGJ) is designated the EGJ area. Tumors having their epicenter in this area are designated EGJ carcinomas irrespective of histological type. The location of an EGJ carcinoma is described using the symbols E (proximal 2 cm segment) and G (distal 2 cm segment), with the dominant area of invasion described first, i.e., E, EG, E=G (both areas equally involved), GE, or G. The distance between the tumor center and the EGJ is recorded.
The EGJ is defined as the border between the esophageal and gastric muscles. Clinically this is identified by one of the following: (a) the distal end of the longitudinal palisading small vessels in the lower esophagus at endoscopy; (b) the horizontal level of the angle of His shown by barium meal examination; (c) the proximal end of the longitudinal folds of the greater curve of the stomach shown at endoscopy or barium meal study; or (d) the level of the macroscopic caliber change of the resected esophagus and stomach. It is important to note that the squamocolumnar junction (SCJ) does not always coincide with the EGJ.
Clinically, the tumor location is often expressed as cardia, fundus, body, incisura, and antrum.
Cross-sectional parts of the stomach
The stomach's cross-sectional circumference is divided into four equal parts: the lesser (Less) and greater (Gre) curvatures, and the anterior (Ant) and posterior (Post) walls (Fig. 2) . Circumferential involvement is recorded as Circ. (Table 3) .
Description of macroscopic type
The macroscopic tumor type should be recorded in both the clinical and pathological classifications. (Table 4) Where a malignant epithelial tumor consists of more than one histological subtype, the different histological components should be recorded in descending order of the surface area occupied, e.g., tub 1 [ pap (see table below).
Histological classification

Depth of tumor invasion (T)
The depth of tumor invasion is recorded as the T-category. Conventional characters denoting depth of tumor invasion are also recorded: M, SM, MP, SS, SE, SI (see below). The prefixes ''c'' and ''p'' are used in conjunction with the T-category and not with the characters M, SM, etc. (e.g., a pathologically diagnosed mucosal tumor should be recorded as pT1a, not pM). Tumor invasion into the muscularis mucosa is included in the M category. Early gastric cancer comprises of T1 tumors irrespective of lymph node metastasis. T4a Tumor invasion is contiguous to the serosa or penetrates the serosa and is exposed to the peritoneal cavity (SE) The lymph nodes (LNs) of the stomach are defined and given station numbers, as shown in Table 5 and Figs. 7, 8, 9. Lymph node stations 1-12 and 14v are defined as regional gastric lymph nodes; metastasis to any other nodes is classified as M1.
In tumors invading the esophagus, lymph node numbers 19, 20, 110, and 111 are included as regional lymph nodes. For carcinomas arising in the remnant stomach with a gastrojejunostomy, jejunal lymph nodes adjacent to the anastomosis are included as regional lymph nodes. Please refer to the ''Gastric Cancer Treatment Guidelines'' [1] for a detailed account of which lymph nodes are to be dissected in gastric resection with curative intent.
Recording of lymph node metastasis
For surgical resection specimens, the total number of lymph nodes and the number of involved lymph nodes at each nodal station are recorded. When a tumor nodule without histological evidence of lymph node structure is found in the lymphatic drainage area of the primary tumor, it is recorded as extranodal metastasis and counted as a metastatic lymph node in the pN determination. Although it is not a prerequisite, the examination of 16 or more regional lymph nodes is recommended for N status determination. 
Metastatic ratio of lymph nodes The metastatic ratio is the ratio of metastatic nodes to the total number of
Distant metastasis
Metastasis to sites other than regional lymph nodes (distant metastasis) is M1 disease. In addition, peritoneal metastasis, peritoneal lavage cytology, and hepatic metastasis may be described by the conventional symbols P, CY, and H, respectively (see below). Positive peritoneal lavage cytology is recorded as cy? by the International Union Against Cancer (UICC)/TNM system. 
Presence or absence and sites of distant metastasis (M)
MX
Peritoneal lavage cytology (CY)
CYX: Peritoneal cytology not performed CY0: Peritoneal cytology negative for carcinoma cells CY1: Peritoneal cytology positive for carcinoma cells A macroscopically curative resection with CY1 is R1.
Hepatic metastasis (H)
HX: Hepatic metastasis is unknown H0: No hepatic metastasis H1: Hepatic metastasis. 
Stage grouping
Vertical margin (VM)
VMX Involvement of the vertical margin cannot be assessed VM0 No involvement of the vertical margin VM1 Involvement of the vertical margin.
Residual tumor (R)
The presence or absence of residual tumor after surgery is described as the R status; R0 is a curative resection with negative resection margins; R1 and R2 are non-curative resections. For example: A large adenocarcinoma with computed tomography (CT) evidence of serosal irregularity and lymph node metastasis was classified as cT4aN1M0. Preoperative chemotherapy achieved significant tumor regression, with the tumor being undetectable by endoscopy and CT (ycT0N0M0). Gastrectomy was performed and histological examination revealed viable carcinoma cells in the muscularis propria and in two regional lymph nodes; granulation tissue with mucin lakes was present in five other lymph nodes (ypT2N1M0).
Histological evaluation criteria of tumor response
after preoperative therapy (Fig. 8) The histological response of the primary tumor should be evaluated in the section where the tumor is thought to have been located at the pretreatment assessment and in the sections where tumor cells are likely to remain. Viable tumor cells are defined as cells which are judged to be capable of proliferation.
Grade 0 (no effect) No evidence of effect Grade 1 (slight effect) No viable tumor cells remain. It is recommended that the finding is confirmed on additional sectioning.
Response evaluation of chemotherapy and radiotherapy
Tumor response to chemotherapy and/or radiotherapy is assessed using the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 [2] .
The Japanese Gastric Cancer Association (JGCA) developed an original method to evaluate the response of the primary gastric lesion to chemotherapy or radiotherapy [3] , but it was not widely used, mainly because of technical difficulties. In the RECIST, primary gastric tumors are regarded as non-target lesions and endoscopic diagnosis is not recommended as an objective evaluation. However, the response of the primary tumor is clinically important and the JGCA methods may provide useful information in future neoadjuvant trials. The results of response evaluation of the primary tumor made by the following methods can be recorded and used as information that is additional to the RECIST results in some trial settings.
JGCA response evaluation of primary tumor
Tumor response, morphological changes, and efficacy are evaluated by double-contrast barium meal study and/or endoscopic examination of the following three types of primary lesions.
Measurable lesions (a-lesions)
Reduction rate = (longest diameter before therapy -longest diameter after therapy)/longest diameter before therapy.
Evaluable but not measurable lesions (b-lesions)
(i) Describe changes in protruded lesions as follows:
Progression, no change, regression, flattening, or disappearance
(ii) Describe changes in excavated lesions as follows:
• Raised margin: progression, no change, regression, flattening, or disappearance • Crater: progression, no change, regression, flattening, or disappearance.
3.3.1.3 Diffusely infiltrating lesions (c-lesions) [3] In diffusely infiltrating tumors (type 4), treatment response may be evaluated by expansion of the gastric lumen. In principle, the squares of the lesion shown with standing barium X-ray examination are compared before and after therapy, at the same position with the same volume of barium, and the enlargement rate is calculated. Enlargement rate = (product calculated before therapy) -(product calculated after therapy)/(product calculated before therapy) 9 100% 3.3.1.4 Definition of response in primary lesion
Disappearance of all tumor lesions and no diagnosis of carcinoma. Biopsy specimens are negative for carcinoma.
• Partial response (PR) a-lesions: At least a 30% decrease in total size b-lesions: Remarkable regression and flattening of a tumor on X-ray/endoscopic examinations, which roughly corresponds to at least a 50% decrease in tumor size. c-lesions: At least 50% enlargement of the gastric lumen in the area of the lesions by X-ray examination.
• Stable disease (SD) Changes in tumor size or shape are less than PR, but are not progressive disease (PD). 
Preparation of the resected stomach
After gross inspection and measurement of any serosal tumor involvement (Fig. 9) , the stomach is, in principle, opened along the greater curvature. On examination from the mucosal side, the tumor size and the length of the proximal and distal resection margins are measured (Fig. 10 ).
Fixation of the resected stomach
After dissection of the lymph nodes from the specimen, the stomach is placed on a flat board with the mucosal side up, pinned at the edges with stainless steel pins, and fixed in a 10% buffered formalin solution. A relatively short fixation time (48 h) is recommended for additional immunohistochemical or genetic examinations in the future.
Sectioning of the stomach
Firstly a section is taken along the lesser curvature as a reference line to assess background mucosal changes. In Type 0 superficial tumors, a set of sections parallel to the reference line should be made at 5-to 7-mm intervals (Fig. 11) . In advanced tumors, the area of deepest invasion should be sectioned parallel to the reference line. If there is concern about tumor margins, additional sections should be taken (Fig. 12) . In multiple tumors or tumors of unusual configuration, suitable sectioning to obtain accurate findings must be devised on a case-by-case basis. The carcinoma in a remnant stomach should be sectioned taking into account its relationship with the suture line and anastomosis.
Sectioning of lymph nodes
Each dissected lymph node should be studied individually.
The plane of largest dimension of the node including the hilus should be sectioned.
Handling of endoscopically resected specimens
A single resection procedure performed for a single lesion is defined as ''en-bloc resection'', and multiple resection procedures for a single lesion are defined as ''piecemeal resection''.
Fixation, inspection, and sectioning
The specimen is spread out, pinned on a flat board, and fixed in 10% buffered formalin solution. The size of the specimen, the size and shape of the tumor, and the margins should be recorded on a schematic diagram. The proximal and distal margins are indicated. Fixed materials should be sectioned serially at 2-mm intervals parallel to a line that includes the closest resection margin of the specimen (Fig. 13) . When resection margin involvement cannot be denied on a rebuilt diagram such as that shown in Fig. 14 , sectioning should be added to examine the true margin.
Histological diagnosis
The following should be recorded.
• The size and number of specimens Depth is determined and recorded only when the vertical margin is negative for cancer invasion. When submucosal invasion is present, the actual measured length (in microns) from the lower border of the muscularis mucosae should also be recorded. If the muscularis mucosae is obscure due to ulcerative changes, the length should be measured on the virtual line based on the adjacent normal layer.
When the vertical margin is involved, the possibility of deeper invasion should be described.
• Intratumoral ulcerative findings UL(-): Ulcer or ulcer scar is absent UL(?): Ulcer or ulcer scar is present.
• Capillary invasion ly(-): Lymphatic invasion is absent ly(?): Lymphatic invasion is present v(-): Venous invasion is absent v(?): Venous invasion is present.
• Horizontal margin involvement HMX: Horizontal margin involvement is unknown HM0: Horizontal margin is not involved (The length of the margin should be recorded) HM1: Horizontal margin is involved (The number of positive sections should be recorded).
• Vertical margin involvement VMX: Vertical margin involvement is unknown VM0: Vertical margin is not involved VM1: Vertical margin is involved.
4.7 Histological diagnosis of gastric biopsy (''Group Classification'')
Principles
This classification is applied only to endoscopic biopsy materials. Materials obtained by polypectomy, endoscopic resection, or surgery are not included. The ''Group Classification'' is applied only to epithelial tissue. In principle, the diagnosis is written first, followed by the Group Classification.
Classification
Group X Inappropriate material for which histological diagnosis cannot be made Group 1 Normal tissue or non-neoplastic lesion 
